Complications of mini-percutaneous nephrolithotomy and standard percutaneous nephrolithotomy: A comparative study

Author:

Sharif Rawaz Azad Hamad1,Jawad Nihad Rifaat1

Affiliation:

1. Department of Surgery, College of Medicine, Hawler Medical University, Erbil, Iraq

Abstract

Abstract Background: Percutaneous nephrolithotomy (PCNL) is a major surgical procedure and the preferred treatment of choice for renal calculi (medium and large) size. Objectives: The study aims to determine complications between mini-PCNL and standard-PCNL, which is a comparative study to show which one has fewer complications and is safer for a patient with better outcomes. Materials and Methods: In a 1-year prospective study, clinical data from 44 patients who underwent PCNL (standard and mini) type between February 2021 and March 2022 for renal stones in Erbil city. Inclusion criteria included patients with renal stones (stag-horn, partial stag-horn, and non-stag-horn) and who are performing PCNL procedures. The exclusion criteria included patients who have a contraindication for doing PCNL. Results: Forty-four patients participated in the study, 17 underwent mini-PCNL, and 27 underwent standard PCNL. The mean hospital stay among the standard PCNL group (2.5 days) was significantly (P = 0.005) higher than that of the mini-PCNL group (1.7 days). Postoperative fever, infection, and sepsis (25%), bleeding (15.9%), hematuria (65.9%), and retained stone (20.5%). However, the differences in these rates were not significant between the groups. The rate of extravasation in the standard PCNL group (25.9%) was significantly (P = 0.032) higher than that of the mini-PCNL group (0%). Around two-thirds (64.7%) of the mini-PCNL group had no pain, compared with only 11.1% of the standard PCNL group (P = 0.001). Conclusion: The effectiveness of mini-PCNL is still under observation. Mini-PCNL postoperatively with less pain and limitation of blood loss, and less hospitalization for patients, with excellent results for stone free in comparison with standard PCNL.

Publisher

Medknow

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3